Endurance Wealth Management, Inc. Outlook Therapeutics, Inc. Transaction History
Endurance Wealth Management, Inc.
- $731 Million
- Q2 2023
A detailed history of Endurance Wealth Management, Inc. transactions in Outlook Therapeutics, Inc. stock. As of the latest transaction made, Endurance Wealth Management, Inc. holds 20,000 shares of OTLK stock, worth $114,800. This represents 0.0% of its overall portfolio holdings.
Number of Shares
20,000
Previous 10,000
100.0%
Holding current value
$114,800
Previous $11,000
218.18%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding OTLK
# of Institutions
3Shares Held
31.5KCall Options Held
0Put Options Held
0About Outlook Therapeutics, Inc.
- Ticker OTLK
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 226,144,992
- Market Cap $1.3B
- Description
- Outlook Therapeutics, Inc., a late clinical-stage biopharmaceutical company, focuses on developing and commercializing monoclonal antibodies for various ophthalmic indications. Its lead product candidate is ONS-5010, an ophthalmic formulation of bevacizumab product candidate that is in Phase-III clinical trial for the treatment of wet age-relate...